BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dianzani C, Foglietta F, Ferrara B, Rosa AC, Muntoni E, Gasco P, Della Pepa C, Canaparo R, Serpe L. Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model. World J Gastroenterol 2017; 23(23): 4200-4210 [PMID: 28694660 DOI: 10.3748/wjg.v23.i23.4200]
URL: https://www.wjgnet.com/1007-9327/full/v23/i23/4200.htm
Number Citing Articles
1
Chi-Pin James Wang, Min Ji Byun, Se-Na Kim, Wooram Park, Hee Ho Park, Tae-Hyung Kim, Jung Seung Lee, Chun Gwon Park. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatmentJournal of Controlled Release 2022; 345: 1 doi: 10.1016/j.jconrel.2022.02.028
2
Nidhi Mishra, Samipta Singh, Priyanka Maurya, Raquibun Nisha, Shubhini A. Saraf. Nanoformulations in Human Health2020; : 133 doi: 10.1007/978-3-030-41858-8_7
3
Tania Limongi, Francesca Susa, Marco Allione, Enzo di Fabrizio. Drug Delivery Applications of Three-Dimensional Printed (3DP) Mesoporous ScaffoldsPharmaceutics 2020; 12(9): 851 doi: 10.3390/pharmaceutics12090851
4
Prasad Minakshi, Rajesh Kumar, Mayukh Ghosh, Basanti Brar, Manju Barnela, Preeti Lakhani. Application of Polymeric Nano-Materials in Management of Inflammatory Bowel DiseaseCurrent Topics in Medicinal Chemistry 2020; 20(11): 982 doi: 10.2174/1568026620666200320113322
5
Murtada A. Oshi, Adnan Haider, Muhammad Irfan Siddique, Alam Zeb, Syed Babar Jamal, Atif Ali Khan Khalil, Muhammad Naeem. Nanomaterials for chronic inflammatory diseases: the current status and future prospectsApplied Nanoscience 2021;  doi: 10.1007/s13204-021-02019-8
6
Manu Sharma, Shipra Sharma, Jyoti Wadhwa. Improved uptake and therapeutic intervention of curcumin via designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorderArtificial Cells, Nanomedicine, and Biotechnology 2019; 47(1): 45 doi: 10.1080/21691401.2018.1543191
7
Fransisca Leonard, Srimeenakshi Srinivasan, Xuewu Liu, Eva-Maria Collnot, Mauro Ferrari, Claus-Michael Lehr, Biana Godin. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel diseaseEuropean Journal of Pharmaceutics and Biopharmaceutics 2020; 151: 61 doi: 10.1016/j.ejpb.2020.03.020
8
Romain Brusini, Mariana Varna, Patrick Couvreur. Advanced nanomedicines for the treatment of inflammatory diseasesAdvanced Drug Delivery Reviews 2020; 157: 161 doi: 10.1016/j.addr.2020.07.010
9
Aoibhín Ryan, Pratikkumar Patel, Paula M. O'Connor, Jennifer Cookman, R. Paul Ross, Colin Hill, Sarah P. Hudson. Single versus double occupancy solid lipid nanoparticles for delivery of the dual-acting bacteriocin, lacticin 3147European Journal of Pharmaceutics and Biopharmaceutics 2022; 176: 199 doi: 10.1016/j.ejpb.2022.05.016
10
Mei Yang, Yujie Zhang, Yana Ma, Xiangji Yan, Liuyun Gong, Mingzhen Zhang, Baojun Zhang. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospectsJournal of Bio-X Research 2020; 3(4): 157 doi: 10.1097/JBR.0000000000000078
11
Kristina Lechner, Mahira Zeeshan, Maxi Noack, Hussain Ali, Markus F. Neurath, Benno Weigmann. Small but powerful: will nanoparticles be the future state‐of‐the‐art therapy for IBD?Expert Opinion on Drug Delivery 2022; 19(3): 235 doi: 10.1080/17425247.2022.2043847
12
Giuseppe Cappellano, Cristoforo Comi, Annalisa Chiocchetti, Umberto Dianzani. Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune DiseaseInternational Journal of Molecular Sciences 2019; 20(1): 204 doi: 10.3390/ijms20010204
13
Maria J Barahona, Vanessa Baratta, Jenna Ollodart, David Mulligan, John P Geibel. Design and implementation of novel nutraceuticals and derivatives for treating intestinal disordersFuture Medicinal Chemistry 2019; 11(8): 847 doi: 10.4155/fmc-2018-0313
14
Esther Prieto, Maria Jose Cardiel, Eugenio Vispe, Miriam Idoipe, Elena Garcia-Martin, Jose Maria Fraile, Vicente Polo, Jose Antonio Mayoral, Luis Emilio Pablo, Maria Jesus Rodrigo. Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulationBiomedical Materials 2020; 15(6): 065021 doi: 10.1088/1748-605X/aba445
15
Vijay Sagar Madamsetty, Reza Mohammadinejad, Ilona Uzieliene, Noushin Nabavi, Ali Dehshahri, Jomarien García-Couce, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, Pooyan Makvandi, Abbas Pardakhty, Abbas Aghaei Afshar, Ali Seyfoddin. Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery SystemsACS Biomaterials Science & Engineering 2022; 8(5): 1763 doi: 10.1021/acsbiomaterials.2c00026
16
Shangjun Fu, Zongyun He, Yongfeng Tang, Bo Lan. Effect of Mn3O4 Nanoparticles on Lipopolysaccharide-Induced Inflammatory Factors in the Human Tendon Cells and Its MechanismInternational Journal of Polymer Science 2020; 2020: 1 doi: 10.1155/2020/1934732
17
Hai‑Lian Du, Ai‑Dong Zhai, Hong Yu. Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat modelMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10865
18
Advancement of nanomedicines in chronic inflammatory disordersInflammopharmacology 2022; 30(2): 355 doi: 10.1007/s10787-022-00927-x
19
Mohamed H. Desoqi, Hossam S. El-Sawy, Elsayed Kafagy, Mamdouh Ghorab, Shadeed Gad. Fluticasone propionate–loaded solid lipid nanoparticles with augmented anti-inflammatory activity: optimisation, characterisation and pharmacodynamic evaluation on ratsJournal of Microencapsulation 2021; 38(3): 177 doi: 10.1080/02652048.2021.1887383
20
Abdul Shakur Khan, Kifayat Ullah Shah, Mohammed Al Mohaini, Abdulkhaliq J. Alsalman, Maitham A. Al Hawaj, Yousef N. Alhashem, Shakira Ghazanfar, Kamran Ahmad Khan, Zahid Rasul Niazi, Arshad Farid. Tacrolimus-Loaded Solid Lipid Nanoparticle Gel: Formulation Development and In Vitro Assessment for Topical ApplicationsGels 2022; 8(2): 129 doi: 10.3390/gels8020129
21
Fengqian Chen, Qi Liu, Yang Xiong, Li Xu. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel DiseaseInternational Journal of Nanomedicine 2021; : 4225 doi: 10.2147/IJN.S310952
22
Ameeduzzafar Zafar, Nabil K Alruwaili, Syed Sarim Imam, Mohd Yasir, Omar Awad Alsaidan, Ali Alquraini, Alenazy Rawaf, Bader Alsuwayt, Md. Khalid Anwer, Sultan Alshehri, Mohammed M. Ghoneim. Development and Optimization of Nanolipid-Based Formulation of Diclofenac Sodium: In Vitro Characterization and Preclinical EvaluationPharmaceutics 2022; 14(3): 507 doi: 10.3390/pharmaceutics14030507
23
Kelly Van Looveren, Charlotte Wallaeys, Claude Libert. Potential of glucocorticoids to treat intestinal inflammation during sepsisCurrent Opinion in Pharmacology 2020; 53: 1 doi: 10.1016/j.coph.2019.12.005
24
Muhammad Naeem, Uzma Azeem Awan, Fazli Subhan, Jiafu Cao, Shwe Phyu Hlaing, Juho Lee, Eunok Im, Yunjin Jung, Jin-Wook Yoo. Advances in colon-targeted nano-drug delivery systems: challenges and solutionsArchives of Pharmacal Research 2020; 43(1): 153 doi: 10.1007/s12272-020-01219-0
25
Rahul Mittal, Amit P. Patel, Vasanti M. Jhaveri, Sae-In S. Kay, Luca H. Debs, James M. Parrish, Debbie R. Pan, Desiree Nguyen, Jeenu Mittal, Rahul Dev Jayant. Recent advancements in nanoparticle based drug delivery for gastrointestinal disordersExpert Opinion on Drug Delivery 2018; 15(3): 301 doi: 10.1080/17425247.2018.1420055
26
Fanny Giron, Anna Pastó, Ennio Tasciotti, Bincy P Abraham. Nanotechnology in the Treatment of Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2019; 25(12): 1871 doi: 10.1093/ibd/izz205
27
Bapi Gorain, Sreenivas Patro Sisinthy, Hira Choudhury, Prashant Kesharwani. Theory and Applications of Nonparenteral Nanomedicines2021; : 209 doi: 10.1016/B978-0-12-820466-5.00010-7
28
Lauren J. Mohan, Jacqueline S. Daly, Barbara M. Ryan, Zebunnissa Ramtoola. The future of nanomedicine in optimising the treatment of inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2019; 54(1): 18 doi: 10.1080/00365521.2018.1563805
29
D Raju. Case studies of enhanced pharmacodynamic activity of poorly oral bioavailable drugs via solid lipid nanoparticlesJournal of Drug Delivery and Therapeutics 2021; 11(2): 204 doi: 10.22270/jddt.v11i2.4582
30
Aoibhín Ryan, Pratikkumar Patel, Paula M. O’Connor, R. Paul Ross, Colin Hill, Sarah P. Hudson. Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147Drug Delivery and Translational Research 2021; 11(4): 1735 doi: 10.1007/s13346-021-00984-9